Perioperative management of upper tract urothelial carcinoma in the Nordic countries.
Humans
Scandinavian and Nordic Countries
/ epidemiology
Carcinoma, Transitional Cell
/ surgery
Ureteral Neoplasms
/ surgery
Kidney Neoplasms
/ surgery
Guideline Adherence
/ statistics & numerical data
Perioperative Care
/ methods
Nephroureterectomy
Practice Guidelines as Topic
Practice Patterns, Physicians'
/ statistics & numerical data
Guideline
Nephroureterectomy
Survey
Upper tract urothelial carcinoma
Journal
BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571
Informations de publication
Date de publication:
25 Jun 2024
25 Jun 2024
Historique:
received:
04
10
2023
accepted:
10
06
2024
medline:
25
6
2024
pubmed:
25
6
2024
entrez:
24
6
2024
Statut:
epublish
Résumé
Upper tract urothelial carcinoma (UTUC) is a rare malignancy, with typically only few new cases annually per urological department. Adherence to European association of urology (EAU) guidelines on UTUC in the Nordic countries is unknown. The objective of this survey was to examine the implementation of EAU guidelines, the perioperative management and organization of the treatment of UTUC in the Nordic countries. The electronic survey was distributed to 93 hospitals in the Nordic countries performing radical nephroureterectomy (NU). The survey consisted of 57 main questions and data was collected between December 1st, 2021 and April 23rd, 2022. Overall response rate was 47/93 (67%) with a completion rate of 98%. Five out of the 6 examined subjects on diagnostic practice are applied by ≥ 72% of the participating centers. NU as treatment for high-risk UTUC is performed by 37/47 (79%), and 91% include a bladder cuff excision. Adherence to EAU guidelines is high on diagnostic practice in the Nordic countries, whereas disease management is less coherent.
Sections du résumé
BACKGROUND
BACKGROUND
Upper tract urothelial carcinoma (UTUC) is a rare malignancy, with typically only few new cases annually per urological department. Adherence to European association of urology (EAU) guidelines on UTUC in the Nordic countries is unknown. The objective of this survey was to examine the implementation of EAU guidelines, the perioperative management and organization of the treatment of UTUC in the Nordic countries.
METHODS
METHODS
The electronic survey was distributed to 93 hospitals in the Nordic countries performing radical nephroureterectomy (NU). The survey consisted of 57 main questions and data was collected between December 1st, 2021 and April 23rd, 2022.
RESULTS
RESULTS
Overall response rate was 47/93 (67%) with a completion rate of 98%. Five out of the 6 examined subjects on diagnostic practice are applied by ≥ 72% of the participating centers. NU as treatment for high-risk UTUC is performed by 37/47 (79%), and 91% include a bladder cuff excision.
CONCLUSIONS
CONCLUSIONS
Adherence to EAU guidelines is high on diagnostic practice in the Nordic countries, whereas disease management is less coherent.
Identifiants
pubmed: 38914985
doi: 10.1186/s12894-024-01515-7
pii: 10.1186/s12894-024-01515-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
132Informations de copyright
© 2024. The Author(s).
Références
Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, et al. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol. 2017;35:379–87.
doi: 10.1007/s00345-016-1928-x
pubmed: 27604375
Rouprêt M, Babjuk M, Compérat E, Gontero P, Liedberg F, Masson-Lecomte A et al. Upper Urinary Tract Urothelial Carcinoma EAU Guidelines on. 2022.
Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Widmer H, et al. Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma. BJU Int. 2010;105:799–804.
doi: 10.1111/j.1464-410X.2009.08818.x
pubmed: 19725824
Hendricksen K, Aziz A, Bes P, Chun FKH, Dobruch J, Kluth LA, et al. Discrepancy between European Association of Urology Guidelines and Daily Practice in the management of non–muscle-invasive bladder Cancer: results of a European Survey. Eur Urol Focus. 2019;5:681–8.
doi: 10.1016/j.euf.2017.09.002
pubmed: 29074050
Gontero P, Babjuk M. Swedish national guidelines on urothelial cancer echo the EAU guidelines but with some regional dialect. Scandinavian J Urol. 2022;56:147–8.
doi: 10.1080/21681805.2022.2057585
Baack Kukreja JE, Messing EM, Shah JB. Are we doing better? The discrepancy between perception and practice of enhanced recovery after cystectomy principles among urologic oncologists. Urologic Oncology: Seminars and Original Investigations. 2016;34:120.e17-120.e21.
Aslan G, Baltaci S, Cal C, Turkeri L, Gunlusoy B, Adsan O, et al. Bowel preparation and peri-operative management for radical cystectomy in Turkey: Turkish Urooncology Association multicenter survey. Urol J. 2011;8:113–9.
pubmed: 21656469
Kondo T, Hara I, Takagi T, Kodama Y, Hashimoto Y, Kobayashi H, et al. Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: a prospective study. Int J Urol. 2014;21:453–9.
doi: 10.1111/iju.12338
pubmed: 24754341
Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, et al. Diagnosis and treatment of non-muscle invasive bladder Cancer: AUA/SUO Guideline. J Urol. 2016;196:1021–9.
doi: 10.1016/j.juro.2016.06.049
pubmed: 27317986
Oedorf K, Skaaheim Haug E, Liedberg F, Järvinen R, Bjerggaard Jensen J, Arum CJ, et al. Perioperative management of radical cystectomy in the nordic countries. Scand J Urol. 2019;0:1–5.
Blaerecancer D, Dablaca G. Klinisk Retningslinje Kraeft - Udredning.
Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, et al. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU Int. 2012;110:1134–41.
doi: 10.1111/j.1464-410X.2012.10960.x
pubmed: 22394612
Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Alasker A, et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. Eur J Cancer. 2009;45:3291–7.
doi: 10.1016/j.ejca.2009.06.016
pubmed: 19615885
Jeldres C, Lughezzani G, Sun M, Isbarn H, Shariat SF, Budaus L, et al. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J Urol. 2010;183:1324–9.
doi: 10.1016/j.juro.2009.12.018
pubmed: 20171666
Dominguez-Escrig JL, Peyronnet B, Seisen T, Bruins HM, Yuan CY, Babjuk M, et al. Potential benefit of Lymph Node Dissection during Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a systematic review by the European Association of Urology Guidelines Panel on non–muscle-invasive bladder Cancer. Eur Urol Focus. 2019;5:224–41.
doi: 10.1016/j.euf.2017.09.015
pubmed: 29158169
Dong F, Xu T, Wang X, Shen Y, Zhang X, Chen S, et al. Lymph node dissection could bring survival benefits to patients diagnosed with clinically node-negative upper urinary tract urothelial cancer: a population-based, propensity score-matched study. Int J Clin Oncol. 2019;24:296–305.
doi: 10.1007/s10147-018-1356-6
pubmed: 30334174
Moschini M, Foerster B, Abufaraj M, Soria F, Seisen T, Roupret M, et al. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy. World J Urol. 2017;35:1541–7.
doi: 10.1007/s00345-017-2026-4
pubmed: 28247066
Zareba P, Rosenzweig B, Winer AG, Coleman JA. Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract. Cancer. 2017;123:1741–50.
doi: 10.1002/cncr.30516
pubmed: 28152158
Lenis AT, Donin NM, Faiena I, Salmasi A, Johnson DC, Drakaki A et al. Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma. Urologic Oncology: Seminars and Original Investigations. 2018;36:9.e1-9.e9.
Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Sun M, Pharand D, et al. A critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma. Urology. 2010;75:118–24.
doi: 10.1016/j.urology.2009.07.1296
pubmed: 19864000
Blaerecancer D, Dablaca G. Klinisk Retningslinje Kraeft- Behandling.
Birtle A, Johnson M, Chester J, Jones R, Dolling D, Bryan RT, et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. 2020;395:1268–77.
doi: 10.1016/S0140-6736(20)30415-3
pubmed: 32145825
pmcid: 7181180
Sui W, Wallis CJD, Luckenbaugh AN, Barocas DA, Chang SS, Penson DF, et al. The impact of Hospital volume on short-term and long-term outcomes for patients undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Urology. 2020. https://doi.org/10.1016/j.urology.2020.07.062 .
Sun M, Bianchi M, Trinh QD, Abdollah F, Schmitges J, Jeldres C, et al. Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy. J Urol. 2012;187:405–10.
doi: 10.1016/j.juro.2011.10.025
pubmed: 22177151
Joshi SS, Handorf EA, Zibelman M, Plimack ER, Uzzo RG, Kutikov A, et al. Treatment facility volume and survival in patients with metastatic renal cell carcinoma: a Registry-based analysis. Eur Urol. 2018;74:387–93.
doi: 10.1016/j.eururo.2018.05.025
pubmed: 29880274
pmcid: 7548437
Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon Volume and Operative Mortality in the United States. 2003.
Becker A, Bianchi M, Hansen J, Tian Z, Shariat SF, Popa I, et al. Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample. World J Urol. 2014;32:1511–21.
doi: 10.1007/s00345-014-1256-y
pubmed: 24515596
Capolicchio JP, Saemi A, Trotter S, Plante MK. Retroperitoneoscopic nephrectomy with a modified hand-assisted approach. Urology. 2011;77:607–11.
doi: 10.1016/j.urology.2010.05.046
pubmed: 20708224
Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A. Higher surgeon and hospital volume improves long-term survival after radical cystectomy. Cancer. 2013;119:3546–54.
doi: 10.1002/cncr.28235
pubmed: 23839861
Konety BR, Allareddy V, Modak S, Smith B. Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better? J Clin Oncol. 2006;24:2006–12.
doi: 10.1200/JCO.2005.04.2622
pubmed: 16648501
Tinay I, Gelpi-Hammerschmidt F, Leow JJ, Allard CB, Rodriguez D, Wang Y, et al. Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10-year population-based analysis. BJU Int. 2016;117:954–60.
doi: 10.1111/bju.13375
pubmed: 26573216